Finance
Aktietilbagekøbsprogram - uge 39
Nasdaq Copenhagen Euronext Dublin London Stock Exchange Finanstilsynet Øvrige interessenter
Sep 28 · 06:59GlobeNewswire
31,858 press releases indexed under finance.
Nasdaq Copenhagen Euronext Dublin London Stock Exchange Finanstilsynet Øvrige interessenter
Nasdaq Copenhagen Euronext Dublin London Stock Exchange Danish Financial Supervisory Authority Other stakeholders
(PR-inside.com) Physitrack plc (Nasdaq First North:PTRK) launches AI agentic EMR that turns the consultation itself into the clinical record, moving the company from a tool inside the clinician's stack to the system of record the stack runs on. LONDON, GB / ACCESS Newswire / September 28, 2026 / Physitrack PLC (STO:PTRK) d/b/a Physitrack Group, a global provider of AI-powered software for healthcare and workplace wellbeing, today announced the launch of its own electronic medical record (EMR) for physical therapy and rehabilitation practices in the United States. The launch represents a strategic expansion of Physitrack's existing offering. Historically, Physitrack has operated alongside third-party electronic ..
I medfør af kapitalmarkedsloven § 24, oplyser DLR Kredit hermed om ekstraordinære indfrielser pr. fredag den 25. september 2026. Oplysningerne fremgår af vedhæftede fil. Denne meddelelse er offentliggjort med henblik på opfyldelse af transparensdirektivets krav om offentliggørelse. Oplysningerne vil endvidere på sædvanlig måde blive formidlet via Nasdaq Copenhagen. Spørgsmål kan rettes til: Head of Rating & IR Jakob Kongsgaard Olsson tlf. nr. 33 42 07 06.
NANJING, China, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs” or the “Company,” Stock Code: 9887.HK) today announced that opamtistomig (LBL-024), the Company’s proprietary PD‑L1/4‑1BB bispecific antibody, has been granted Orphan Drug Designation (ODD) by Japan’s Ministry of Health, Labour and Welfare (MHLW) for the treatment of extrapulmonary neuroendocrine carcinoma (EP-NEC). This is the third Orphan Drug Designation for opamtistomig, following designations in the U.S. Food and Drug Administration (FDA) and the European Commission (EC), marking a further expansion of its global regulatory recognition into a strategically important Asian market.
(PR-inside.com) NEW YORK, NY / ACCESS Newswire / September 28, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Rackspace Technology, Inc. (NASDAQ:RXT) securities. If you suffered a loss on your Rackspace Technology, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Rackspace Technology, Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed against ..
Til Nasdaq Copenhagen
To the Nasdaq Copenhagen
Til Nasdaq Copenhagen
To the Nasdaq Copenhagen
LOS ANGELES, Sept. 28, 2026 /PRNewswire/ -- Schall, Brown & Schwartz LLP ("SBS"), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Bloom Energy Corporation ("Bloom" or "the Company") (NYSE: BE) for violations of §§10(b) and 20(a) of the...
NEW YORK, Sept. 28, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against DNOW Inc. ("DNOW" or "the Company") (NYSE: DNOW) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S....